porcin
epidem
diarrhea
ped
acut
highli
contagi
enter
diseas
pig
caus
porcin
epidem
diarrhea
viru
pedv
characterist
clinic
sign
pedv
infect
vomit
wateri
diarrhea
dehydr
weight
loss
pig
age
suscept
pedv
infect
neonat
piglet
week
age
highest
mortal
rate
reach
pedv
initi
report
europ
earli
spread
wide
multipl
swineproduc
countri
sinc
emerg
highli
virul
pedv
strain
decim
swine
farm
china
strain
spread
unit
state
wipe
pig
popul
america
less
year
sinc
new
highvirul
pedv
strain
repeatedli
emerg
mani
swinerais
countri
lead
devast
econom
loss
world
swine
industri
sever
highli
virul
variant
emphas
import
develop
effect
method
control
spread
infect
pedv
member
alphacoronaviru
genu
within
famili
coronavirida
order
nidoviral
pedv
possess
kb
singlestrand
positivesens
rna
genom
encod
seven
open
read
frame
orf
orf
among
first
gene
orf
encod
larg
replicas
polyprotein
process
gener
nonstructur
protein
orf
encod
structuralaccessori
protein
includ
spike
protein
nonstructur
accessori
protein
envelop
e
protein
membran
protein
nucleocapsid
n
protein
respect
protein
type
glycoprotein
play
crucial
role
viru
attach
entri
receptor
bind
cell
membran
fusion
induct
neutral
antibodi
protein
cleav
residu
subunit
residu
host
proteas
subunit
contain
ntermin
domain
ntd
residu
show
sialic
acid
bind
activ
ctermin
domain
ctd
residu
attach
cell
surfac
receptor
eg
aminopeptidas
n
apn
subunit
mediat
membran
fusion
protein
excel
target
vaccin
develop
induct
protect
immun
pedv
sever
studi
confirm
antibodi
especi
neutral
antibodi
stimul
vaccin
express
spike
protein
abl
protect
host
pedv
infect
addit
neutral
antibodi
pedv
develop
candid
passiv
protect
lee
et
al
report
egg
yolk
antibodi
igi
domain
spike
protein
effici
protect
neonat
piglet
pedv
support
potenti
antibodi
reagent
prophylact
therapeut
agent
protect
piglet
pedv
infect
genet
engin
recombin
antibodi
fragment
increasingli
use
medic
diagnosi
therapi
mani
diseas
singl
chain
fragment
variabl
scfv
also
call
singlechain
antibodi
one
popular
type
genet
engin
antibodi
scfv
consist
variabl
light
chain
vl
heavi
chain
vh
connect
short
peptid
linker
advantag
scfv
small
size
low
immunogen
high
specif
abil
genet
engin
scfv
produc
bacteri
express
system
largescal
product
although
scfv
smaller
fulllength
igg
retain
complet
antigen
bind
site
sever
scfv
produc
control
viru
infect
includ
scfv
chicken
infecti
bursal
diseas
viru
scfv
target
human
influenza
viru
scfv
phosphoprotein
newcastl
diseas
viru
thu
scfv
consid
potenti
reagent
prevent
treatment
viral
diseas
present
report
select
porcin
scfv
target
porcin
pathogen
studi
construct
scfv
phage
display
librari
use
peripher
blood
lymphocyt
piglet
induc
pedv
scfv
pedv
select
neutral
effici
evalu
confirm
mechan
scfv
neutral
pedv
occur
bind
viral
spike
protein
immunoprophylact
therapeut
properti
scfv
neonat
piglet
pedv
infect
explor
result
provid
foundat
develop
scfvbase
drug
prevent
treatment
pedv
infect
anim
experi
perform
accord
recommend
laid
guidelin
use
laboratori
anim
provid
scienc
technolog
commiss
shanghai
municip
stcsm
protocol
approv
ethic
committe
shanghai
jiaotong
univers
school
agricultur
biolog
approv
number
vero
cell
line
hek
cell
line
cultur
dulbecco
modifi
eagl
essenti
medium
dmem
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
fb
gibco
grand
island
ny
usa
penicillinstreptomycin
invitrogen
cell
cultur
incub
intestin
porcin
epitheli
cell
line
kindli
provid
prof
jianxiong
xv
maintain
medium
supplement
fb
incub
atmospher
pedv
genbank
access
number
propag
vero
cell
presenc
tosyl
phenylalanyl
chloromethyl
keton
tpck
treat
trypsin
worthington
lakewood
nj
usa
construct
pedv
domainexpress
plasmid
pedv
domain
amplifi
upstream
primer
contain
ecor
underlin
ttgaattcatgaagtctttaacctacttc
downstream
primer
contain
xho
underlin
ttctcgagtcatttacaacgagagttaccatt
pedv
domain
amplifi
upstream
primer
contain
ecor
underlin
ttgaattcatgagtcaagattgcacccac
downstream
primer
contain
xho
underlin
ttctcgagtcactgcacgtggaccttttc
pcr
product
insert
thermo
scientif
inc
waltham
usa
form
respect
recombin
plasmid
verifi
sequenc
indirect
immunofluoresc
assay
ifa
confluent
vero
cell
cultur
infect
pedv
harvest
cell
show
viral
cytopath
effect
viru
particl
suspens
purifi
sucros
densiti
gradient
centrifug
previous
describ
result
band
sucros
solut
collect
syring
remov
sucros
presenc
concentr
viral
particl
determin
elisa
total
pedv
serumposit
crossbre
larg
white
pig
purchas
local
breed
farm
blood
sampl
collect
pig
use
isol
peripher
blood
lymphocyt
pbl
total
rna
extract
pbl
use
trizol
reagent
invitrogen
use
templat
synthes
fulllength
cdna
primer
amplif
heavychain
variabl
region
vh
lightchain
variabl
region
vl
list
tabl
first
step
pcr
vh
gene
vl
gene
includ
amplifi
respect
second
step
pcr
amplifi
vl
ad
linker
sequenc
gener
vllinker
final
vh
vllinker
ligat
togeth
form
fulllength
scfv
soepcr
scfv
pcr
product
separ
electrophoresi
extract
gel
use
commerci
kit
thermo
scientif
inc
purifi
fragment
insert
linear
vector
biovector
inc
beij
china
recombin
dna
transform
escherichia
coli
compet
cell
biovector
electropor
micropuls
biorad
hercul
ca
usa
grown
ytag
plate
ampicillin
glucos
librari
size
calcul
count
coloni
transform
bacteria
recombin
phagemid
transform
cell
infect
helper
phage
gener
rescu
phage
particl
elisa
plate
coat
purifi
pedv
particl
overnight
block
nonfat
milk
pb
rescu
phage
ad
well
unbound
phage
remov
wash
time
pbst
time
pb
pedvbind
phage
elut
addit
glycinehcl
buffer
ph
log
phasegrown
e
coli
infect
elut
phage
plate
onto
ytag
plate
total
four
round
biopan
perform
phage
elisa
use
assess
phage
bound
pedv
plate
coat
pedv
particl
ph
block
nonfat
milk
incub
recombin
phage
particl
wash
pbst
select
phage
deriv
last
round
biopan
detect
hrpconjug
monoclon
antibodi
dilut
od
valu
nm
measur
use
micropl
reader
biotek
winooski
vt
usa
scfv
gene
sequenc
interest
subclon
vector
scfv
express
induc
mm
iptg
sigmaaldrich
st
loui
mo
usa
bacteri
cell
lyse
sonic
scfv
protein
purifi
use
ninta
hisbind
resin
column
merck
madison
wi
usa
accord
manufactur
instruct
wash
column
two
time
ml
wash
buffer
mm
nacl
mm
sodium
phosphat
buffer
mm
imidazol
ph
scfv
bound
column
elut
elut
buffer
mm
nacl
mm
sodium
phosphat
buffer
mm
imidazol
ph
elut
scfv
assess
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
subsequ
experi
elut
scfv
dialyz
ml
pb
h
chang
pb
everi
h
purifi
scfv
concentr
use
centrifug
filter
cutoff
merck
quantifi
use
bicinchonin
acid
assay
kit
thermo
scientif
inc
store
cytotox
activ
scfv
vero
cell
determin
use
bromid
mtt
assay
thermo
scientif
inc
briefli
approxim
cellswel
seed
cell
cultur
plate
cultur
overnight
next
morn
scfv
twofold
serial
dilut
pb
alon
ad
well
cell
incub
h
mtt
solut
mgml
ad
well
plate
incub
h
supernat
remov
color
formazan
crystal
well
dissolv
addit
sdshcl
solut
sigmaaldrich
od
valu
nm
measur
use
micropl
reader
biotek
cell
surviv
rate
calcul
scfv
treatment
pb
treatment
determin
whether
scfv
pedv
possess
neutral
activ
plaqu
reduct
neutral
prn
assay
perform
briefli
purifi
scfv
combin
cocktail
contain
mgml
scfv
adjust
mgml
filter
use
membran
subsequ
scfv
serial
dilut
incub
equal
volum
pedv
multipl
infect
moi
h
scfvviru
mixtur
inocul
onto
confluent
monolay
vero
cell
plate
incub
h
posit
control
viru
scfv
blank
control
viru
scfv
neg
control
viru
nonrel
scfv
also
ad
well
cell
overlaid
dmem
contain
low
melt
agaros
sigmaaldrich
tpcktreat
trypsin
h
incub
cell
fix
formaldehyd
min
stain
crystal
violet
solut
min
number
plaqu
determin
manual
count
plaqu
reduct
rate
scfv
calcul
use
formula
averag
number
plaqu
dilutionaverag
number
plaqu
posit
control
well
neutral
antibodi
titer
calcul
reciproc
highest
serum
dilut
reduc
viru
plaqu
count
scfv
combin
cocktail
scfv
combin
cocktail
test
triplic
vero
cell
hek
cell
grown
confluenc
coverslip
sixwel
plate
transfect
infect
pedv
moi
h
postinfect
h
posttransfect
cell
fix
paraformaldehyd
permeabil
triton
block
normal
goat
serum
tiangen
biotech
beij
china
block
nonspecif
bind
site
incub
purifi
scfv
h
three
wash
pb
tag
antibodi
fitc
antibodi
dilut
abcam
cambridg
usa
ad
imag
stain
cell
visual
use
nikon
eclips
fluoresc
microscop
nikon
sendai
japan
ascertain
whether
scfv
recogn
differ
epitop
pedv
antigen
addit
elisa
perform
calcul
addit
index
ai
briefli
plate
coat
pedv
antigen
incub
overnight
scfv
abl
satur
coat
antigen
ad
alon
combin
incub
wash
bound
scfv
detect
addit
hrpconjug
antihi
mous
antibodi
yeasen
shanghai
china
normal
mous
serum
use
neg
control
competit
scfv
determin
calcul
ai
use
follow
equat
ai
repres
valu
two
scfv
test
repres
valu
two
scfv
mix
ai
two
scfv
recogn
differ
antigen
epitop
two
scfv
recogn
antigen
epitop
stabil
scfv
gastric
condit
evalu
use
simul
gastric
fluid
sgf
sgf
contain
mgml
pepsin
sigmaaldrich
nacl
ph
purifi
scfv
ad
sgf
pb
control
incub
shake
h
antibodi
activ
defin
abil
scfv
bind
pedv
assess
elisa
result
express
rel
activ
use
follow
formula
valu
scfv
treat
valu
scfv
treat
pb
stabil
scfv
intestin
condit
evalu
use
simul
intestin
fluid
sif
sif
contain
mgml
pancreatin
sigmaaldrich
ph
purifi
scfv
ad
sif
pb
control
incub
shake
h
scfv
activ
determin
elisa
result
express
rel
activ
use
follow
formula
valu
scfv
treat
sif
valu
scfv
treat
pb
two
crossbr
larg
white
pig
oral
administr
ml
purifi
scfv
use
flexibl
gavag
feed
needl
tianyuan
anim
instrument
inc
shandong
china
h
post
inocul
pig
human
euthan
section
jejunum
collect
fix
formalin
h
immers
sucros
h
tissu
sampl
embed
oct
compound
sakura
finetek
radnor
pa
usa
section
thick
use
cryomicrotom
leica
wetzlar
germani
cryosect
sampl
transfer
onto
polylysin
pretreat
slide
stain
antihi
monoclon
antibodi
sigmaaldrich
primari
antibodi
follow
fitc
conjug
goat
antimous
antibodi
secondari
antibodi
section
omit
primari
antibodi
neg
control
sampl
visual
fluoresc
microscopi
nikon
crossbr
larg
white
piglet
obtain
pedv
seroneg
pregnant
sow
local
breed
farm
birth
piglet
hous
separ
steril
isol
fed
commerci
steril
milk
water
experi
group
assign
measur
prophylact
effici
scfv
surviv
piglet
pedv
challeng
twelv
piglet
randomli
divid
three
group
n
scfv
ad
milk
adjust
final
concentr
day
age
group
oral
administ
ml
scfvsmilk
mixtur
five
time
per
day
use
flexibl
gavag
feed
needl
tianyuan
anim
instrument
inc
group
group
oral
administ
pbsmilk
mixtur
five
time
per
day
next
day
group
oral
inocul
ml
dmem
contain
pfupiglet
pedv
challeng
exposur
group
oral
administ
correspond
scfvsmilk
pbsmilk
mixtur
anoth
two
day
anim
monitor
day
presenc
clinic
symptom
includ
diarrhea
vomit
anorexia
depress
sever
clinic
symptom
evalu
fecal
sampl
collect
rectum
use
swab
use
quantifi
viral
shed
evalu
sever
diarrhea
fecal
consist
score
follow
normal
fece
diarrhea
pasti
fece
mild
diarrhea
semiliquid
fece
moder
diarrhea
liquid
fece
sever
diarrhea
experi
group
assign
measur
prophylact
effici
scfv
small
intestin
piglet
pedv
challeng
nine
piglet
randomli
divid
three
group
n
treatment
piglet
group
piglet
group
respect
day
post
challeng
dpc
piglet
group
human
euthan
subject
patholog
histolog
examin
necropsi
lesion
small
intestin
observ
small
intestin
tissu
collect
piglet
fix
formalin
fix
specimen
trim
process
embed
paraffin
rehydr
stain
hematoxylin
eosin
h
e
stain
section
observ
light
microscopi
olympu
tokyo
japan
fecal
sampl
homogen
pb
frozen
thaw
time
centrifug
g
min
total
rna
extract
supernat
cdna
gener
use
revers
transcript
kit
qpcr
perform
reaction
volum
contain
templat
forward
revers
primer
rox
refer
dye
sybr
green
qpcr
premix
clontech
mountain
view
ca
usa
qpcr
reaction
carri
abi
realtim
pcr
system
appli
biosystem
foster
ca
usa
follow
condit
initi
revers
transcript
min
follow
initi
denatur
min
cycl
min
primer
sequenc
list
tabl
detect
limit
assay
determin
gener
standard
curv
serial
dilut
known
amount
vitrotranscrib
rna
qpcr
standard
curv
pedv
qpcr
slope
indic
amplif
effici
detect
limit
calcul
rna
copi
per
ml
viral
genom
copi
number
per
ml
determin
sampl
assess
triplic
field
experi
carri
pig
farm
outbreak
diarrhea
winter
fecalintestin
sampl
collect
piglet
wateri
diarrhea
viral
rna
extract
use
templat
rtpcr
pedv
transmiss
gastroenter
viru
tgev
porcin
deltacoronaviru
pdcov
two
farm
show
pedv
posit
result
chosen
applic
scfv
scfv
ad
milk
adjust
final
concentr
piglet
two
fourdayold
show
symptom
diarrhea
oral
administr
ml
scfvsmilk
three
time
per
day
piglet
inocul
pbsmilk
serv
neg
control
number
death
surviv
piglet
record
everi
day
five
day
mortal
calcul
five
day
first
administr
scfv
data
express
mean
standard
error
mean
sem
data
compar
signific
use
student
test
oneway
anova
sa
softwar
packag
sa
institut
inc
campu
drive
cari
nc
usa
pvalu
consid
statist
signific
viral
particl
purifi
sucros
densiti
gradient
centrifug
subject
elisa
confirm
immunogen
result
show
purifi
pedv
could
use
antigen
screen
pedvspecif
scfv
figur
antibodi
titer
pig
immun
infect
pedv
evalu
indirect
elisa
data
shown
rna
extract
pbl
transcrib
cdna
three
round
pcr
perform
obtain
bp
scfv
gene
fragment
figur
b
scfv
fragment
subclon
linear
vector
confirm
endonucleas
digest
figur
recombin
plasmid
transform
cell
construct
scfv
librari
librari
size
determin
cfuml
count
coloni
plate
librari
size
suitabl
scfv
select
four
round
biopan
perform
screen
pedvbound
scfv
scfv
phage
display
use
pedv
bait
compar
round
final
output
titer
increas
cfuml
tabl
output
rate
third
fourth
round
order
magnitud
indic
suffici
highaffin
antibodi
could
screen
four
round
consecut
biopan
obtain
specif
highaffin
clone
pedv
phage
elisa
perform
fortyeight
clone
randomli
pick
final
round
phage
display
librari
posit
pedvbind
clone
obtain
valu
sampleneg
among
posit
phage
clone
three
scfv
show
rel
higher
od
valu
select
studi
figur
scfv
design
pzz
pzz
pzz
respect
dna
sequenc
pzz
pzz
pzz
confirm
vh
gene
fragment
connect
vl
gene
fragment
linker
deduc
amino
acid
sequenc
posit
clone
align
use
softwar
http
amino
acid
sequenc
analysi
use
imgt
softwar
http
wwwimgtorgimgtvquestvquest
reveal
porcin
scfv
belong
immunoglobulin
vh
heavi
chain
pzz
pzz
light
chain
pzz
light
chain
align
cdr
sequenc
reveal
high
variabl
heavi
light
variabl
chain
especi
figur
sinc
vector
contain
n
ctermini
scfv
purifi
use
ninta
bind
resin
sdspage
indic
scfv
success
purifi
solubl
correct
fold
form
figur
molecular
weight
purifi
protein
kda
correspond
predict
size
purifi
scfv
protein
also
subject
western
blot
result
show
purifi
scfv
react
mous
antihi
tag
antibodi
figur
confirm
whether
purifi
scfv
specif
bound
pedv
ifa
assay
perform
result
show
pzz
pzz
pzz
stain
pedvinfect
vero
cell
react
uninfect
control
cell
indic
purifi
scfv
specif
bound
pedv
figur
mtt
assay
perform
investig
possibl
cytotox
pzz
pzz
pzz
toward
vero
cell
growth
shown
figur
differ
concentr
scfv
show
effect
vero
cell
prolifer
addit
pzz
pzz
pzz
show
cytotox
effect
toward
porcin
cell
line
suggest
scfv
also
safe
intestin
porcin
epitheli
cell
figur
determin
whether
three
scfv
neutral
pedv
infect
prn
assay
perform
scfv
show
affin
pedv
elisa
use
neg
control
two
serial
dilut
scfv
work
stock
test
triplic
shown
tabl
viru
neutral
titer
pzz
pzz
pzz
respect
tabl
neutral
activ
observ
neg
control
scfv
result
demonstr
scfv
potenti
neutral
viral
infect
vitro
mix
three
scfv
cocktail
mgml
scfv
investig
whether
combin
scfv
might
better
effect
neutral
viru
infect
use
alon
result
show
cocktail
scfv
neutral
viral
infect
demonstr
superior
effect
use
scfv
alon
tabl
cocktail
three
scfv
use
anim
experi
pedv
spike
protein
known
target
pedvneutr
antibodi
sinc
pzz
pzz
pzz
show
neutral
effect
pedv
infect
clarifi
whether
scfv
could
specif
recogn
spike
protein
lab
previous
construct
eukaryot
express
vector
harbor
fulllength
spike
protein
howev
transfect
cell
show
weak
fluoresc
observ
ifa
solv
problem
construct
express
domain
domain
spike
protein
respect
express
plasmid
confirm
ifa
assay
use
antipedv
polyclon
antibodi
shown
figur
scfv
react
protein
protein
empti
vector
result
indic
pzz
pzz
pzz
specif
bound
domain
protein
neutral
viral
infect
figur
compar
recogn
antigen
epitop
pedv
antigen
scfv
addit
elisa
perform
calcul
ai
valu
ai
valu
result
combin
pzz
pzz
pzz
respect
ai
valu
pzz
pzz
result
confirm
pzz
pzz
pzz
recogn
differ
epitop
pedv
antigen
tabl
order
evalu
success
deliveri
small
intestin
pig
oral
administr
purifi
scfv
section
jejunum
collect
immunohistochemistri
perform
use
antihi
tag
monoclon
antibodi
fitc
conjug
goat
antimous
antibodi
observ
signal
scfv
villi
lamina
propria
muscular
propria
figur
data
suggest
purifi
scfv
success
deliv
small
intestin
effect
gastric
condit
scfv
evalu
use
sgf
interv
h
sampl
collect
neutral
mm
stop
proteolyt
reaction
indirect
elisa
perform
analyz
scfv
activ
treatment
sgf
result
show
pzz
pzz
pzz
maintain
activ
h
postincub
sgf
respect
even
h
postincub
sgf
scfv
activ
still
detect
sgf
figur
effect
small
intest
condit
scfv
evalu
use
sif
interv
h
sampl
collect
store
stop
reaction
scfv
activ
sif
treatment
assess
elisa
result
show
scfv
significantli
affect
incub
sif
h
p
activ
scfv
retain
antibodi
activ
h
incub
sif
figur
passiv
immun
antibodi
effect
method
protect
piglet
pedv
infect
confirm
prophylact
effici
scfv
piglet
oral
administ
cocktail
three
scfv
challeng
preval
pedv
strain
clinic
sign
observ
challeng
phase
list
tabl
challeng
piglet
group
show
diarrhea
day
dpc
dpc
piglet
group
develop
sever
diarrhea
piglet
group
recov
diarrhea
figur
compar
one
piglet
group
show
mild
moder
diarrhea
onset
diarrhea
delay
dpc
piglet
recov
diarrhea
dpc
figur
addit
diarrhea
piglet
group
also
show
clinic
sign
includ
loss
appetit
mental
depress
see
tabl
mortal
observ
group
wherea
piglet
group
die
day
postinfect
see
tabl
figur
viral
shed
pedv
quantifi
realtim
pcr
base
detect
pedv
n
gene
rectal
sampl
collect
piglet
everi
day
viru
challeng
group
piglet
start
shed
viru
stool
dpc
peak
viral
rna
titer
copiesml
dpc
figur
group
pedv
viru
start
detect
dpc
continu
seven
day
highest
fecal
pedv
rna
titer
significantli
lower
group
p
see
tabl
figur
result
indic
scfv
treatment
could
inhibit
viral
replic
shed
pedvinfect
piglet
surviv
piglet
group
human
euthan
dpc
necropsi
group
show
typic
viral
enter
includ
thin
transpar
wall
small
intestin
fluid
fill
small
intestin
lesion
observ
small
intestin
group
data
shown
histolog
examin
reveal
length
jejunum
villi
shorten
sever
fractur
small
intestin
mucosa
necrosi
villou
atrophi
extens
intestin
epitheli
degener
observ
group
figur
group
acinar
structur
small
portion
intestin
remain
intact
figur
taken
togeth
result
indic
scfv
could
provid
protect
piglet
pedv
infect
fortyfour
sampl
piglet
wateri
diarrhea
dehydr
subject
pedv
tgev
pdcov
diagnosi
shown
tabl
sampl
pedv
posit
sampl
tgev
pdcov
posit
therapeut
effici
scfv
test
farm
show
pedv
posit
result
part
piglet
litter
oral
administr
scfvsmilk
mixtur
everyday
piglet
litter
inocul
pbsmilk
surviv
rate
day
inocul
increas
significantli
scfvsmilk
treat
piglet
compar
control
group
tabl
result
indic
piglet
protect
pedv
infect
scfv
new
variant
pedv
emerg
china
high
morbid
mortal
suckl
piglet
emerg
pedv
strain
genet
distinct
classic
vaccin
strain
character
delet
insert
amino
acid
substitut
gene
compar
strain
even
though
mani
swine
popul
immun
classic
vaccin
could
provid
limit
crossneutr
activ
swine
popul
new
variant
strain
thu
lead
immun
failur
strain
use
present
studi
isol
piglet
show
typic
ped
clinic
symptom
belong
genotyp
new
variant
strain
repres
epidem
pandem
field
strain
china
use
strain
antigen
select
specif
porcin
scfv
could
neutral
viru
infect
prophylact
effici
scfv
also
evalu
tradit
strategi
protect
piglet
pedv
infect
immun
pregnant
sow
inactiv
attenu
vaccin
neutral
antibodi
produc
colostrum
milk
sow
newborn
piglet
passiv
protect
pedv
suckl
immun
dam
lactogen
immun
although
vaccin
wide
use
consid
effect
sow
develop
solid
lactogen
immun
due
immun
rout
vaccin
suck
pig
still
vulner
infect
unless
obtain
adequ
matern
antibodi
milk
addit
method
provid
protect
postwean
piglet
pedvspecif
antibodi
rapidli
lost
postwean
piglet
becom
suscept
pedv
moreov
amino
acid
sequenc
mutat
new
variant
strain
caus
immun
failur
commerci
vaccin
base
aspect
feed
foreign
antibodi
passiv
immun
piglet
suitabl
vaccin
prevent
neonat
diarrheal
diseas
egg
yolk
immunoglobulin
igi
chicken
immun
pedv
antigen
administ
piglet
result
show
igi
abl
reduc
mortal
piglet
challeng
exposur
although
igi
prepar
immun
chicken
characterist
high
affin
larg
yield
simpl
isol
process
product
cost
highqual
igi
largescal
applic
still
remain
higher
commerci
antibiot
vaccin
sinc
igi
chicken
origin
might
caus
immunogen
side
effect
host
studi
scfv
prepar
pig
immun
infect
pedv
sinc
host
immun
system
stimul
specif
pathogen
pedvinduc
pig
abund
matur
antibodi
bias
pedv
four
round
biopan
three
scfv
high
affin
pedv
success
screen
predict
amino
acid
sequenc
two
scfv
align
analyz
result
show
variat
complementari
determin
region
cdr
significantli
greater
framework
region
fr
length
vl
vh
equal
among
three
scfv
indic
presenc
amino
acid
insert
delet
region
sinc
cdr
contribut
specif
bind
specif
epitop
differ
divers
cdr
vl
vh
domain
may
reflect
differ
bind
epitop
scfv
synergist
andor
addit
effect
cocktail
neutral
antibodi
recogn
differ
epitop
report
numer
studi
differ
virus
accord
occup
model
multihit
theori
neutral
procur
suffici
antibodi
densiti
surfac
viral
pathogen
crucial
pivot
factor
viral
neutral
along
recognit
neutral
epitop
procedur
may
feasibl
mani
case
singl
epitop
recogn
achiev
one
epitop
recogn
viral
surfac
studi
mix
three
scfv
cocktail
investig
whether
combin
scfv
would
better
effect
neutral
viral
infect
compar
use
alon
result
show
viru
neutral
titer
cocktail
scfv
neutral
titer
individu
scfv
thu
cocktail
three
scfv
use
anim
experi
monoclon
antibodi
scfv
demonstr
neutral
effect
target
viral
surfac
glycoprotein
owe
import
role
viral
adher
host
cell
receptor
analyz
whether
pzz
pzz
pzz
bind
pedv
spike
protein
inhibit
viral
infect
ifa
assay
addit
elisa
confirm
three
scfv
react
differ
epitop
domain
domain
previou
report
shown
main
neutral
epitop
protein
locat
domain
two
neutral
domain
identifi
region
includ
coe
aa
aa
exact
epitop
recogn
scfv
need
elucid
pepscan
elisa
previou
studi
report
major
genet
variat
pedv
concentr
portion
gene
especi
nterminu
gene
even
singl
amino
acid
mutat
region
chang
structur
spike
protein
may
explain
current
vaccin
strain
fail
protect
piglet
new
emerg
variant
strain
studi
confirm
scfv
neutral
pedv
target
domain
whether
three
scfv
also
influenc
pedv
replic
specif
recogn
uniqu
epitop
variant
strain
still
need
studi
confirm
scfv
could
neutral
pedv
infect
vero
cell
subsequ
test
prophylact
efficaci
scfv
neonat
piglet
piglet
inocul
cocktail
scfv
surviv
challeng
virul
pedv
piglet
treat
pb
follow
pedv
infect
show
mortal
suggest
scfv
provid
effect
passiv
immun
viral
infect
piglet
treat
scfv
show
moder
diarrhea
intestin
mucosa
remain
intact
histolog
examin
indic
scfv
could
block
viru
invad
small
intestin
effect
scfv
slightli
influenc
low
ph
enzymat
degrad
gastrointestin
gi
tract
oral
administr
solv
problem
biodegrad
polymer
nanoparticul
chitosan
deriv
protect
protein
degrad
may
prospect
strategi
oral
deliveri
previou
studi
demonstr
possibl
chitosanbas
nanoparticl
carrier
oral
deliveri
antimicrobi
peptid
bacteriophag
antigen
small
interf
rna
sirna
current
focus
select
suitabl
chitosan
deriv
protect
scfv
enzymat
degrad
modul
scfv
pharmacokinet
improv
efficaci
summari
three
scfv
specif
target
pedv
gener
porcin
pbl
scfv
show
nontox
vitro
could
neutral
pedv
infect
bind
differ
epitop
spike
protein
anim
experi
confirm
protect
effici
scfv
piglet
pedv
challeng
field
applic
demonstr
scfv
oral
administr
could
reduc
mortal
piglet
best
knowledg
first
report
examin
antivir
activ
porcin
origin
scfv
pedv
result
provid
basi
develop
scfvbase
drug
treatment
prevent
pedvinduc
diarrhea
